| IPI00033008 - FOS, PROTO-ONCOGENE PROTEIN C-FOS. | |
|---|---|
| Uniprot Accession: Q76MZ0 | |
| Uniprot ID: Q76MZ0_HUMAN | |
| Mapping: Chr 14, 74815284 - 74818685 | |
| Entrez Gene: 2353 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_6481) |
|---|
| Rat: Fos, PROTO-ONCOGENE PROTEIN C-FOS. |
| Mouse: Fos, PROTO-ONCOGENE PROTEIN C-FOS. |
| Human: FOS, PROTO-ONCOGENE PROTEIN C-FOS. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| nucleus | C | TAS | IDA IC IDA ISS | TAS ISS ISS IEA |
| transcription factor complex | C | IEA | IDA | ISS IEA |
| protein heterodimerization activity | F | IDA | ||
| double-stranded DNA binding | F | IDA | ||
| transcription factor activity | F | IEA | IDA IMP | TAS ISS IEA |
| sequence-specific DNA binding | F | IEA | IEA | IEA |
| protein dimerization activity | F | IEA | IEA | |
| DNA binding | F | IDA | IDA ISS | |
| specific RNA polymerase II transcription factor activity | F | TAS | ISS | |
| cellular process | P | IEA | ||
| regulation of progression through cell cycle | P | IEA | ||
| DNA methylation | P | TAS | ISS | |
| inflammatory response | P | TAS | ISS | |
| nervous system development | P | IEA | IMP | ISS IEA |
| regulation of transcription, DNA-dependent | P | IDA IMP | ISS IEA | |
| regulation of transcription from RNA polymerase II promoter | P | TAS | ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| craniofacial phenotype | MP | Un Un | ||
| life span-post-weaning/aging | MP | Un | ||
| behavior/neurological phenotype | MP | Un Un Un | ||
| endocrine/exocrine gland phenotype | MP | Un | ||
| growth/size phenotype | MP | Un Un | ||
| other phenotype | MP | Un | ||
| immune system phenotype | MP | Un Un | ||
| embryogenesis phenotype | MP | Un | ||
| lethality-embryonic/perinatal | MP | Un | ||
| skeleton phenotype | MP | Un Un | ||
| nervous system phenotype | MP | Un Un | ||
| hematopoietic system phenotype | MP | Un Un | ||
| tumorigenesis | MP | Un Un | ||
| hearing/vestibular/ear phenotype | MP | Un | ||
| normal phenotype | MP | Un | ||
| limbs/digits/tail phenotype | MP | Un Un | ||
| reproductive system phenotype | MP | Un | ||
| vision/eye phenotype | MP | Un | ||
| impaired hematopoiesis | N | IEA | ||
| osteoporosis | N | IEA | ||
| abnormal bone remodeling | N | IEA | ||
| postnatal growth retardation | N | IEA | ||
| failure of tooth eruption | N | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| T cell receptor signaling pathway (04660) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| B cell receptor signaling pathway (04662) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Toll-like receptor signaling pathway (04620) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Colorectal cancer (05210) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |